Table 3. Pathway level analysis. Pathway with adjusted P-value ≤0.1 for both mean variance tests are reported.
| Pathway name | q-value mean | q-value variance |
|---|---|---|
| Amyotrophic lateral sclerosis (ALS) | 0 | 0 |
| Arachidonic acid metabolism | 0 | 0 |
| Bacterial invasion of epithelial cells | 0 | 0.09 |
| Bladder cancer | 0 | 0 |
| Calcium signaling pathway | 0 | 0.09 |
| Chemical carcinogenesis | 0 | 0.09 |
| Colorectal cancer | 0 | 0 |
| Dilated cardiomyopathy | 0 | 0 |
| Drug metabolism - cytochrome P450 | 0 | 0.09 |
| Epstein-Barr virus infection | 0 | 0 |
| ErbB signaling pathway | 0 | 0 |
| Ether lipid metabolism | 0 | 0 |
| Folate biosynthesis | 0 | 0 |
| Glycerophospholipid metabolism | 0 | 0.09 |
| Hypertrophic cardiomyopathy (HCM) | 0 | 0 |
| Melanoma | 0 | 0.09 |
| Metabolism of xenobiotics by cytochrome P450 | 0 | 0.09 |
| One carbon pool by folate | 0 | 0 |
| p53 signaling pathway | 0 | 0 |
| TGF-beta signaling pathway | 0 | 0 |
| Type II diabetes mellitus | 0 | 0 |
| Viral myocarditis | 0 | 0 |